SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 21, 2000, Pages 6095-6100

An α-particle emitting antibody ([213bi]j591) for radioimmunotherapy of prostate cancer

(16) McDevitt, Michael R a Barendswaard, Els a Ma, Dangshe a Lai, Lawrence a Curcio, Michael J a Sgouros, George a Ballangrud, Åse M a Yang, Wei Hong a Finn, Ronald D a Pellegrini, Virginia a Geerlings, Maurits W d Lee, Mona a Brechbiel, Martin W c Bander, Neil H b Cordon Cardo, Carlos a Scheinberg, David A a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

b WEILL CORNELL MEDICAL COLLEGE (United States)

c NATIONAL CANCER INSTITUTE (United States)

d Pharmactinium (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUM195 BI 213; MONOCLONAL ANTIBODY J591 BI 213; N [2 AMINO 3 (4 ISOTHIOCYANATOPHEN YL)PROPYL]CYCLOHEXANE 1,2 DIAMINE N,N',N',N'',N'' PENTAACETIC ACID; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOTHERAPY;

ALPHA PARTICLES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; BISMUTH; CELL DEATH; HUMANS; IMMUNOTOXINS; KINETICS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOISOTOPES; SPHEROIDS, CELLULAR; SUBSTRATE SPECIFICITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034327512 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (238)

References (32)

1
- 0019500152
- Carcinoma of the prostate: The treatment of bone metastases by radiophosphorous
- (1981) Clin. Radiol. , vol.32 , pp. 695-697
- Glaser, M.G.¹ Howard, N.² Waterfall, N.³

2
- 0023008590
- Radionuclides for the alleviation of bone pain in advanced malignancy
- (1986) Clin. Oncol. , vol.5 , pp. 42-47
- Robinson, R.G.¹

3
- 0026750068
- Samarium-153-EDTMP: Pharmacokinetics, toxicity, and pain response using an escalating dose schedule in treatment of metastatic bone cancer
- (1992) J. Nucl. Med. , vol.33 , pp. 1451-1458
- Farhanghi, M.¹ Holmes, R.A.² Volkert, W.A.³ Logan, K.W.⁴ Singh, A.⁵

4
- 14444269199
- Interferon-γ and monoclonal antibody [I-131]-labeled CC49: Outcomes in patients with androgen-independent prostate cancer
- (1998) Clin. Cancer Res. , vol.4 , pp. 643-651
- Slovin, S.F.¹ Scher, H.I.² Divgi, C.R.³ Reuter, V.⁴ Sgouros, G.⁵ Moore, M.⁶ Weingard, K.⁷ Pettengall, A.⁸ Imbriaco, M.⁹ El-Shirbiny, A.¹⁰ Finn, R.D.¹¹ Bronstein, J.¹² Brett, C.¹³ Milenic, D.¹⁴ Dnistrian, A.¹⁵ Shapiro, L.¹⁶ Schlom, J.¹⁷ Larson, S.M.¹⁸

5
- 0028308598
- Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49
- (1994) J. Nucl. Med. , vol.35 , pp. 1017-1022
- Meredith, R.F.¹ Bueschen, A.J.² Khazaeli, M.B.³ Plott, W.E.⁴ Grizzle, W.E.⁵ Wheeler, R.H.⁶ Schlom, J.⁷ Russell, C.D.⁸ Liu, T.⁹ LoBuglio, A.F.¹⁰

6
- 0007173120
- Bismuth labeled antibodies for therapy of prostate carcinomas: Preclinical studies
- (1998) J. Nucl. Med. , vol.39 , pp. 223P-224P
- McDevitt, M.R.¹ Finn, R.D.² Larson, S.M.³ Curcio, M.J.⁴ Bander, N.H.⁵ Brechbiel, M.W.⁶ Sgouros, G.⁷ Geerlings, M.W.⁸ Barendswaard, E.⁹ Scheinberg, D.A.¹⁰

7
- 0030866116
- Monoclonal antibodies to the extracellular domain of the prostate specific membrane antigen also react with tumor vascular endothelium
- (1997) Cancer Res. , vol.57 , pp. 3629-3634
- Liu, H.¹ Moy, P.² Kim, S.³ Xia, Y.⁴ Rajasekaran, A.⁵ Navarro, V.⁶ Knudson, B.⁷ Bander, N.H.⁸

8
- 0032530135
- Constitutive and antibody-induced internalization of prostate-specific membrane antigen
- (1998) Cancer Res. , vol.58 , pp. 4055-4060
- Liu, H.¹ Rajasekaran, A.K.² Moy, P.³ Xia, Y.⁴ Kim, S.⁵ Navarro, V.⁶ Rahmati, R.⁷ Bander, N.H.⁸

9
- 0033168844
- Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm expression in tumor-associated neovasculature
- (1999) Cancer Res. , vol.59 , pp. 3192-3198
- Chang, S.S.¹ Reuter, V.E.² Heston, W.D.W.³ Bander, N.H.⁴ Grauer, L.S.⁵ Gaudin, P.B.⁶

10
- 0000281479
- Targeted therapy for myeloid leukemias: A phase I trial of bismuth-213-HuM195 (anti-CD33)
- (1997) Blood , vol.90 , pp. 2245
- Jurcic, J.G.¹ McDevitt, M.R.² Sgouros, G.³ Ballangrud, A.M.⁴ Finn, R.D.⁵ Geerlings, M.W.⁶ Humm, J.L.⁷ Molinet, R.⁸ Apostolidis, C.⁹ Larson, S.M.¹⁰ Scheinberg, D.A.¹¹

11
- 0002769232
- Phase I trial of targeted α-particle therapy for myeloid leukemias with bismuth-213-HuM195 (anti-CD33)
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18
- Jurcic, J.G.¹ McDevitt, M.R.² Sgouros, G.³ Ballangrud, A.M.⁴ Finn, R.D.⁵ Ma, D.⁶ Hamacher, K.⁷ Geerlings, M.W.⁸ Humm, J.L.⁹ Brechbiel, M.W.¹⁰ Molinet, R.¹¹ Apostolidis, C.¹² Larson, S.M.¹³ Scheinberg, D.A.¹⁴

12
- 0032898445
- α-Emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: Pharmacokinetics, bioactivity, toxicity and chemistry
- (1999) J. Nucl. Med. , vol.40 , pp. 166-176
- Nikula, T.N.¹ McDevitt, M.R.² Wu, C.³ Kozak, R.W.⁴ Garmestani, K.⁵ Brechbiel, M.W.⁶ Curcio, M.J.⁷ Pippin, C.G.⁸ Tiffany-Jones, L.⁹ Finn, R.D.¹⁰ Geerlings, M.W.¹¹ Apostolidis, C.¹² Molinet, R.¹³ Gansow, O.A.¹⁴ Scheinberg, D.A.¹⁵

13
- 0032589014
- 213Bi generator system for therapeutic clinical applications: Construction and operation
- (1999) Appl. Radiat. Isotopes , vol.50 , pp. 895-904
- McDevitt, M.R.¹ Finn, R.D.² Sgouros, G.³ Ma, D.⁴ Scheinberg, D.A.⁵

14
- 0031715792
- Radioimmunotherapy with α-emitting radionuclides
- (1998) Eur. J. Nucl. Med. , vol.25 , pp. 1341-1351
- McDevitt, M.R.¹ Sgouros, G.² Finn, R.D.³ Humm, J.L.⁴ Jurcic, J.G.⁵ Larson, S.M.⁶ Scheinberg, D.A.⁷

15
- 0032888303
- Preparation of α emitting bismuth-213 labeled antibody constructs for clinical use
- (1999) J. Nucl. Med. , vol.40 , pp. 1722-1727
- McDevitt, M.R.¹ Finn, R.D.² Ma, D.³ Larson, S.M.⁴ Scheinberg, D.A.⁵

16
- 0032694040
- 213Bi-HuM195 (anti-CD33) in patients with leukemia
- (1999) J. Nucl. Med. , vol.40 , pp. 1935-1946
- Sgouros, G.¹ Ballangrud, A.M.² Jurcic, J.G.³ McDevitt, M.R.⁴ Humm, J.L.⁵ Erdi, Y.E.⁶ Mehta, B.M.⁷ Finn, R.D.⁸ Larson, S.M.⁹ Scheinberg, D.A.¹⁰

17
- 0027449936
- Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia
- (1993) J. Nucl. Med. , vol.34 , pp. 422-430
- Sgouros, G.¹ Grahm, M.C.² Divgi, C.R.³ Larson, S.M.⁴ Scheinberg, D.A.⁵

18
- 0002566836
- Bismuth-213 imaging: Pre-clinical characterization of an α-particle emitting radionuclide
- (1996) J. Nucl. Med. , vol.37
- Sgouros, G.¹ Humm, J.L.² McDevitt, M.R.³ Kennedy, J.⁴ Schumaker, R.⁵ Larson, S.M.⁶ Scheinberg, D.A.⁷

19
- 0030785406
- Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA
- (1997) Bioorg. Med. Chem. , vol.5 , pp. 1925-1934
- Wu, C.¹ Kobayashi, H.² Sun, B.³ Yoo, T.M.⁴ Paik, C.H.⁵ Gansow, O.A.⁶ Carrasquillo, J.A.⁷ Pastan, I.⁸ Brechbiel, M.W.⁹

20
- 0028902723
- A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies
- (1995) Nucl. Med. Biol. , vol.22 , pp. 387-390
- Nikula, T.K.¹ Curcio, M.J.² Brechbiel, M.W.³ Gansow, O.A.⁴ Finn, R.D.⁵ Scheinberg, D.A.⁶

21
- 0026889408
- Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates
- (1992) Bioconjug. Chem. , vol.3 , pp. 342-345
- Pippin, C.G.¹ Parker, T.A.² McMurry, T.J.³ Brechbiel, M.W.⁴

22
- 85008461118
- Verfahren zur erzeugung von actinium-225 und wismuth-213 European Patent nb. 0 443 479 B1, 1994
- Van Geel, J.N.C.¹ Fuger, J.² Koch, L.³

23
- 0007173121
- 213Bi for alpha immunotherapy
- (1995) ITU Annual Report 1995-(EUR 16368)-Basic Actinide Research , pp. 55
- Van Geel, J.N.C.¹

24
- 0001147757
- 213Bi for α-particle-mediated radioimmunotherapy
- (1997) J. Label. Compds. Radiopharm. , vol.40 , pp. 341
- Boll, R.A.¹ Mirzadeh, S.² Kennel, S.J.³ DePaoli, D.W.⁴ Webb, O.F.⁵

25
- 0017726744
- A simplified method for production and growth of multicellular tumor spheroids
- (1977) Cancer Res. , vol.37 , pp. 3639-3643
- Yuhas, J.M.¹ Li, A.P.² Martinez, A.O.³ Landman, A.J.⁴

26
- 0032697613
- Growth and characterization of LNCaP prostate cancer cell spheroids
- (1999) Clin. Cancer Res. , vol.5 , pp. 3171s-3176s
- Ballangrud, A.M.¹ Yang, W.-H.² Dnistrian, A.³ Lampen, N.M.⁴ Sgouros, G.⁵

27
- 0007171291
- 213Bi-J591 (anti-PSMA) treatment of LNCaP spheroids
- (1998) Proc. Am. Assoc. Cancer Res. , vol.39 , pp. 440
- Yang, W.-H.¹ Ballangrud, A.M.² McDevitt, M.R.³ Finn, R.D.⁴ Geerlings, M.W.⁵ Bander, N.H.⁶ Scheinberg, D.A.⁷ Sgouros, G.⁸

28
- 0032850651
- Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring
- (1999) Clin. Chem. , vol.45 , pp. 1695-1707
- Bidart, J.M.¹ Thuillier, F.² Augereau, C.³ Chalas, J.⁴ Daver, A.⁵ Jacob, N.⁶ Labrousse, F.⁷ Voitot, H.⁸

29
- 0026602518
- Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
- (1992) Cancer Res. , vol.52 , pp. 1598-1605
- Gleave, M.E.¹ Hsieh, J.-T.² Wu, H.-C.³ Von Eshenbach, A.C.⁴ Chung, W.K.⁵

30
- 0020026251
- Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies
- (1982) Science (Washington DC) , vol.215 , pp. 1511-1513
- Scheinberg, D.A.¹ Strand, M.² Gansow, O.A.³

31
- 0020333332
- The in vivo fate of a At-211 labeled monoclonal antibody with a known specificity in a murine system
- (1982) Int. J. Radiat. Oncol. Biol. Phys. , vol.8 , pp. 1943-1946
- Vaughan, A.T.M.¹ Bateman, W.J.² Fisher, D.R.³

32
- 0024509637
- Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195
- (1989) Leukemia (Baltimore) , vol.3 , pp. 339
- Tanimoto, M.¹ Scheinberg, D.A.² Cordon-Cardo, C.³ Huie, D.⁴ Clarkson, B.D.⁵ Old, L.J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.